To rule out NF1 mosaicism, we performed targeted resequencing (Ion AmpliseqTM Comprehensive Cancer Panel, Life technologies®) of NF1 genes using DNA extracted from formalin-fixed paraffin-embedded tissues of the lesion, and found no disease-causing mutation in NF1 gene of the lesion. This evidence concerns the gene NF1 and cancer.